Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence.

ABSTRACT: Epidemiological data on psoriasis in Norway are limited. The aim of this study was to provide objective national data on the incidence and prevalence of psoriasis. Patients registered in the Norwegian Prescription Database with a diagnostic code indicating psoriasis vulgaris on prescriptions were included. During the period 2004 to 2020, 272,725 patients received prescription for psoriasis vulgaris in Norway. During the period 2015 to 2020, 84,432 patients received prescription for psoriasis vulgaris for the first time. In 2020, 71,857 (97.7%) patients received topical, 7,197 (9.8%) conventional systemic and 2,886 (3.9%) biological medication for psoriasis vulgaris. In the period 2015 to 2020, the point prevalence of psoriasis was 3.8-4.6% and the incidence was 0.29-0.25%. Norway is divide

SUBMITTER: Solberg SM 

PROVIDER: S-EPMC10128149 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature